About
SOPHiA GENETICS has demonstrated a proof of concept for real time global variant surveillance of spike protein mutations through the SOPHiA GENETICS' secured peer-network and compared findings to the GISAID timeline. Paragon Genomics SARS-CoV-2 panels powered by SOPHiA DDMTM enables labs to detect current and emerging variants with high accuracy and confidence. In this case study, SOPHiA GENETICS' extensive experience in sequencing analytics generate high-quality viral genome data for better research and surveillance of SARS-CoV-2. 

Research Use Only (RUO), Not for Use in Diagnostic Procedures
The information included has been prepared for and is intended for viewing by a global audience. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult local sales representatives
When
on-demand webinar
Presenter
1621544827-c4c2f08c810f6342
Slawomir Kubrik
Genomic Research Expert, SOPHiA GENETICS
Register To Watch Recording
Full name*
Email Address*
Area of interest
Company*
City*
Country *
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.